SMTI: Sanara Company Aggregate Debts

Sanara MedTech Inc. (SMTI) maintains its production resources in the US, where it develops cutting-edge tissue regeneration solutions. The business relies on the expansion of biopharmaceutical developments into the hospital segment and the growth of distribution. The current standalone debt figure is 0.05. The company's price evolution on the GURU.Markets platform allows for a detailed analysis of the financial dynamics of this dermatological market player.

SMTI: Sanara MedTech, Inc. Company Debts 07/04/2022 - 10/29/2026

Sanara MedTech Inc. (SMTI) - metric breakdowns and financial figures

- share price and consensus valuation forecast:

Price Performance Chart sanaramedtech.com|SMTI - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization Sanara|SMTI - Total Company Value

- balance sheet equity data:

Accounting Value of a Share Sanara MedTech|SMTI - Company Book Value|Market Cap to Net Assets Ratio sanaramedtech.com|SMTI - Company Total Assets

- issuer credit burden and liquidity indicators:

- earnings and valuation multiples information:

SMTI - Company Net Income

Fundamental company analysis:SMTI, Sanara MedTech, Inc.

Investors seek to minimize capital risks amid high volatility. Sanara MedTech Inc. (SMTI) is competing with global behemoths for hospital protocols, a struggle that requires significant resources to validate product efficacy. The volume of liabilities on this chart reflects total borrowed capital, allowing for an assessment of the company's financial leverage. A decline in this curve enhances stability but may indicate a pivot away from advantageous scaling. This balance determines the long-term solvency of the asset.

Competitors of Sanara MedTech Inc.